min yan
Henan Cancer Hospital
10
10
2
N/A
0
3
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+14 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (10)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Liang Li
Zibo Central Hospital
Shared therapeutic areas:
Worked with same sponsors:
Xiuwen Wang
Qilu Hospital of Shandong University
Shared therapeutic areas:
Worked with same sponsors:
Jinnan Gao
Bethune Hospital of Shanxi Province
Shared therapeutic areas:
Worked with same sponsors:
Qingshan Li
Affiliated Hospital of Chengde Medical College
Shared therapeutic areas:
Worked with same sponsors:
Liuzhong Yang
The First Affiliated Hospital of Xinxiang Medical College
Shared therapeutic areas:
Worked with same sponsors:
Jingfen Wang
Linyi Cancer Hospital
Shared therapeutic areas:
Worked with same sponsors:
Liangming Zhang
Yantai Yuhuangding Hospital
Shared therapeutic areas:
Worked with same sponsors:
Xin Zhou
Chongqing University Cancer Hospital
Shared therapeutic areas:
Worked with same sponsors:
Aimin Zang
Affiliated Hospital of Hebei University
Shared therapeutic areas:
Worked with same sponsors:
Yuee Teng
First Hospital of China Medical University
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (10)
Showing 10 of 10 trials
A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer
Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02)
Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure
Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain Metastases
Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer
Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.
A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2
A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBC
A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer
All 10 trials loaded